Mimedx (MDXG) Income towards Parent Company (2011 - 2026)

Mimedx has disclosed Income towards Parent Company across 15 years of filings, most recently posting -$10.9 million for Q1 2026.

• Income towards Parent Company for Q1 2026 came in at -$10.9 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$10.9 million (down 5014.03% YoY), and the FY2024 annual result was $421000.0, up 104.57% from the prior year.
• Income towards Parent Company came in at -$10.9 million for Q1 2026 at Mimedx, down from $217000.0 in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of $9.8 million in Q4 2022 to a low of -$10.9 million in Q2 2022.
• The 4-year median for Income towards Parent Company is -$1.7 million (2023), against an average of -$3.3 million.
• Peak annual rise in Income towards Parent Company reached 4839.7% in 2022, while the deepest fall reached 510.91% in 2022.
• Mimedx's Income towards Parent Company stood at $9.8 million in 2022, then tumbled by 77.73% to $2.2 million in 2023, then plunged by 90.09% to $217000.0 in 2024, then tumbled by 5104.61% to -$10.9 million in 2026.
• The last three Income towards Parent Company figures came in at -$10.9 million (Q1 2026), $217000.0 (Q3 2024), and $4000.0 (Q2 2024), per Business Quant data.